Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2021-09-02 Sale |
2021-09-07 7:17 pm |
Prelude Therapeutics Inc | PRLD | Pierce Christopher EVP and Chief of Business Oper |
17,000 | $41.68 | $708,493 | 211,546 (Direct) |
View |
| 2021-04-29 Sale |
2021-04-30 6:24 pm |
Prelude Therapeutics Inc | PRLD | Pierce Christopher EVP and Chief of Business Oper |
3,295 | $40.29 | $132,765 | 8,073 (Direct) |
View |
| 2021-04-08 Sale |
2021-04-15 7:12 pm |
Prelude Therapeutics Inc | PRLD | Pierce Christopher EVP and Chief of Business Oper |
200 | $40 | $8,000 | 11,368 (Direct) |
View |
| 2021-04-07 Sale |
2021-04-09 5:53 pm |
Prelude Therapeutics Inc | PRLD | Pierce Christopher EVP and Chief of Business Oper |
828 | $40.08 | $33,188 | 11,568 (Direct) |
View |
| 2020-09-29 Purchase |
2020-09-29 8:07 pm |
Prelude Therapeutics Inc | PRLD | Pierce Christopher EVP and Chief of Business Oper |
3,750 | $19 | $71,250 | 3,750 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2021-09-02 Exercise |
2021-09-07 7:17 pm |
N/A N/A |
Prelude Therapeutics Inc | PRLD | Pierce Christopher EVP and Chief of Business Oper |
17,000 | $12.85 | 211,546 (Direct) |
View |
| 2021-09-02 Exercise |
2021-09-07 7:17 pm |
N/A 2030-09-01 |
Prelude Therapeutics Inc | PRLD | Pierce Christopher EVP and Chief of Business Oper |
17,000 | $0 | 211,546 (Direct) |
View |
| 2021-07-20 Option Award |
2021-07-22 6:11 pm |
N/A 2031-07-19 |
Prelude Therapeutics Inc | PRLD | Pierce Christopher EVP and Chief of Business Oper |
85,000 | $0 | 85,000 (Direct) |
View |
| 2021-04-29 Exercise |
2021-04-30 6:24 pm |
N/A N/A |
Prelude Therapeutics Inc | PRLD | Pierce Christopher EVP and Chief of Business Oper |
3,295 | $1.89 | 8,073 (Direct) |
View |
| 2021-04-29 Exercise |
2021-04-30 6:24 pm |
N/A 2030-03-26 |
Prelude Therapeutics Inc | PRLD | Pierce Christopher EVP and Chief of Business Oper |
3,295 | $0 | 8,073 (Direct) |
View |
| 2021-04-08 Exercise |
2021-04-15 7:12 pm |
N/A 2030-03-26 |
Prelude Therapeutics Inc | PRLD | Pierce Christopher EVP and Chief of Business Oper |
200 | $0 | 11,368 (Direct) |
View |
| 2021-04-08 Option Award |
2021-04-15 7:12 pm |
N/A N/A |
Prelude Therapeutics Inc | PRLD | Pierce Christopher EVP and Chief of Business Oper |
200 | $1.89 | 11,368 (Direct) |
View |
| 2021-04-07 Exercise |
2021-04-09 5:53 pm |
N/A 2030-03-26 |
Prelude Therapeutics Inc | PRLD | Pierce Christopher EVP and Chief of Business Oper |
828 | $0 | 11,568 (Direct) |
View |
| 2021-04-07 Option Award |
2021-04-09 5:53 pm |
N/A N/A |
Prelude Therapeutics Inc | PRLD | Pierce Christopher EVP and Chief of Business Oper |
828 | $1.89 | 11,568 (Direct) |
View |
Ownership |
2020-09-24 7:26 pm |
N/A 2030-03-26 |
Prelude Therapeutics Inc | PRLD | Pierce Christopher EVP and Chief of Business Oper |
0 | $0 | 332,870 (Direct) |
View |